Hainan Secco Pharmaceutical Co., Ltd.

Main purpose: Using oseltamivir phosphate capsules provided by Hainan Saike Pharmaceutical Co., Ltd. as the test preparation, according to the relevant provisions of the bioequivalence test, the absorption rate and degree of oseltamivir phosphate capsules (trade name: Tamiflu®/Tamiflu®, reference preparation) owned by Roche Pharma (Schweiz) AG and produced by Delpharm Milano S.r.l. were compared in healthy humans to investigate the bioequivalence of the two preparations. Secondary purpose: To observe the safety of the test preparation oseltamivir phosphate capsules and the reference preparation oseltamivir phosphate capsules (trade name: Tamiflu®/Tamiflu®) in healthy subjects.